Next Step After 'Right To Try'? Senate Hearing Includes Call To Reopen Orphan Drug Act
Executive Summary
Trump Administration’s successful campaign to pass “Right to Try” legislation may be emboldening advocates to push for other policies that will loosen FDA regulatory requirements on rare disease drug development.